胸腺肽联合阿米卡星雾化给药治疗老年重症肺炎对血清suPAR水平及免疫功能指标的价值

朴 莉慧
康生顺民医药科技

摘要

目的：探讨对老年重症肺炎患者给予胸腺肽联合阿米卡星雾化给药治疗的临床疗效及对其血清可溶性尿激酶型纤溶酶原激活物受体（suPAR）水平、免疫功能指标的影响。方法：抽选于2020年5月-2022年4月期间老年重症肺炎患者100例，按随机掷币划分组别，即对照组、研究组，各50例。对照组接受常规治疗，研究组接受胸腺肽+阿米卡星雾化给药治疗。评价及对比两组的疗效、血清suPAR水平、免疫功能、不良反应。结果：研究组的疗效总有效率高于对照组（P＜0.05）；研究组的血清suPAR水平高于对照组（P＜0.05）；研究组的CD3+、CD4+均高于对照组，CD8+低于对照组（P＜0.05）；研究组的不良反应率低于对照组（P＜0.05）。结论：对老年重症肺炎患者给予胸腺肽联合阿米卡星雾化给药治疗，疗效确切，可改善血清suPAR指标，提高机体免疫功能，且不良反应少，具有良好的有效性及安全性。

关键词

重症肺炎；胸腺肽；阿米卡星；血清可溶性尿激酶型纤溶酶原激活物受体；免疫功能

参考

[1] Meiying He, Qin Zhang, Lin Yafa. Efficacy of thymopeptide combined with amikacin atomization administration in senile severe pneumonia and its effect on relevant serum indicators [J]. Chinese Journal of Gerontology, 2020,40 (14): 46-48.

[2] Dan Ja. Efficacy of thymopeptide combined with amikacin in severe pneumonia [J]. Journal of Nanchang University: Medical edition, 2021,61 (5): 108-109.

[3] Chunlei Liu. Efficacy of promoting blood circulation and removing blood stasis combined with amikacin atomization administration in treating severe pneumonia and its effect on lung function and serum cytokines [J]. Journal of Baotou Medical College, 2019,35 (2): 72-73.

[4] Yan Tang, Jiang Huang, TANG, et al. Effect of white tiger soup addition and subtraction combined with thymopeptide _1 in elderly patients with severe pneumonia [J]. Journal of Practical Clinical Medicine, 2017,21 (7): 156-157.

[5] Zhimin Liu, Yuanzhi Guan, Shisong Chen. Clinical effect of thymopilin _1 combined with fibrobronchoscopic pulmonary lavage for the treatment of severe pneumonia complicated with sepsis [J]. Chinese and Foreign Medical Research, 2020,18 (31): 230-321.

[6] Qian Zhu. Effects of thymopeptide 1 immunotherapy on immune function and inflammatory factors levels in elderly patients with severe pneumonia [J]. Electronic Journal of Modern Medicine and Health Research, 2020,4 (19): 44-45.

[7] Haiyuan Zhang, Jingnan Liang, Jun Lei. Effect of amikacin atomization administration on pulmonary function and bacterial clearance effect in patients with severe pneumonia [J]. Hebei Medicine, 2018,40 (2): 117-118.

[8] Yin Sun, Haiyan Wei, Shijie He. Changes and significance of serum suPAR and sTREM-1 levels in patients with severe pneumonia [J]. Shandong Medicine, 2017,57 (22): 202.